FIELD: medicine.
SUBSTANCE: described is adhesive pharmaceutical composition which causes slighter skin irritation, preserves excellent bisopropol stability in medication and allows to introduce pharmacologically efficient amount of bisopropol into living organism continuously. Adhesive composition contains bottom layer, adhesive layer applied onto one surface of bottom layer. Adhesive layer contains bisopropol, polyisobytylene, adhesion-improving agent and organic liquid component compatible with polyisobytylene and adhesion-improving agent. Adhesive pharmaceutical composition has good skin adhesion with slighter irritation and is almost painlessly taken off or removed from skin surface almost without leaving adhesive substance.
EFFECT: bisopropol is hold in medication very stably, and pharmacologically efficient amount of bisopropol can be continuously introduced into li8ving organism through skin surface.
14 cl, 1 dwg, 5 tbl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
DEVICE FOR TRANSDERMAL BISOPROLOL INTRODUCTION | 2008 |
|
RU2440811C2 |
ADHESIVE PLASTER CONTAINING BISOPROLOL | 2011 |
|
RU2526194C2 |
ADHESIVE PREPARATION CONTAINING FENTANYL | 2005 |
|
RU2375050C2 |
TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING AZENAPINE AND POLYSILOXANE OR POLYISOBUTYLENE | 2017 |
|
RU2764443C2 |
ADHESIVE PREPARATION CONTAINING BISOPROLOL | 2016 |
|
RU2725071C2 |
MEDICATION IN FORM OF PLASTER | 2008 |
|
RU2462237C2 |
PERMEABLE PRESSURE-SENSITIVE ADHESIVE | 2011 |
|
RU2575586C2 |
TRANSDERMAL SYSTEM CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY DRUG | 2012 |
|
RU2618413C1 |
ADHESIVE COMPOSITION | 2005 |
|
RU2393877C2 |
PERCUTANEOUSLY ABSORBABLE PREPARATION | 2010 |
|
RU2543639C2 |
Authors
Dates
2010-08-20—Published
2006-09-07—Filed